|1.||Kafi, Kamran: 3 articles (01/2009 - 09/2008)|
|2.||Timmerman, John M: 3 articles (01/2009 - 09/2008)|
|3.||Betting, David J: 3 articles (01/2009 - 09/2008)|
|4.||Zhang, Chaofeng: 2 articles (11/2013 - 01/2013)|
|5.||Shi, Jinjin: 2 articles (11/2013 - 01/2013)|
|6.||Wang, Zhenzhen: 2 articles (11/2013 - 01/2013)|
|7.||Zhang, Zhenzhong: 2 articles (11/2013 - 01/2013)|
|8.||Li, Lulu: 2 articles (11/2013 - 01/2013)|
|9.||Wang, Honghong: 2 articles (11/2013 - 01/2013)|
|10.||Wang, Lei: 2 articles (11/2013 - 01/2013)|
09/15/2008 - "Maleimide Id-KLH vaccines also demonstrated superior efficacy in 38C13 and BCL-1 lymphoma models, where Abs were shown to be critical for protection. "
09/15/2008 - "Maleimide Id-KLH conjugates eradicated A20 lymphoma from most tumor-bearing mice, whereas glutaraldehyde Id-KLH had little efficacy. "
01/01/2009 - "Under increasingly stringent conditions, maleimide Id-KLH vaccines maintained superior efficacy over glutaraldehyde Id-KLH in treating established, disseminated murine lymphoma. "
01/01/2009 - "Using flow cytometry, and western blotting to label free thiols with Alexa Fluor 633 C(5) maleimide dye and N-(biotinoyl)-N-(iodoacetyl) ethylendiamine (BIAM), respectively, we show that parthenolide decreases the level of free exofacial thiols on Granta mantle lymphoma cells. "
02/15/2011 - "In this study, two new near-infrared fluorescent iRGD conjugates, that is, Ac-Cys(IRDye®800CW)-iRGD (1), and its dual labeling analog DOTA-Cys(IRDye®800CW)-iRGD (2) were synthesized via the specific mercapto-maleimide reaction for tumor imaging. "
05/01/1990 - "Studies are in progress to optimize N-(p-[125I]iodophenyl)maleimide radioiodination conditions and to improve the tumor localization."
02/24/2015 - "A GC-specific probe was constructed through "click" reaction between the maleimide moiety of PEG ligand and the thiol group from partly reduced antigastric cancer antibody MGb2. "
09/01/2012 - "These results suggest that N-(1-pyrenyl) maleimide is an attractive maleimide to be tested and developed as anti-cancer drug."
09/01/2012 - "Importantly, we demonstrated that N-(1-pyrenyl) maleimide induces apoptosis in Jurkat T cells and displays the greatest differential cytotoxicity against hematopoietic cancer cells. "
|3.||B-Cell Lymphoma (Lymphoma, B Cell)
01/01/2009 - "We recently described an alternative conjugation method employing maleimide-sulfhydryl chemistry that significantly increased the therapeutic efficacy of Id-KLH vaccines in three different murine B cell lymphoma models, with protection mediated by either CD8(+) T cells or antibodies. "
07/01/2012 - "Delivery of the protease light chain of botulinum neurotoxin type A (BoNT/A) via this TDC accelerated the onset of neuromuscular paralysis, indicative of improved translocation of this enzyme into the presynaptic cytosol with subsequent proteolytic inactivation of synaptosomal-associated protein of molecular mass 25 kDa (SNAP-25), an exocytotic soluble N-ethyl-maleimide-sensitive factor attachment protein receptor (SNARE) essential for neurotransmitter release. "
07/01/2013 - "The tLyp-1-NP was prepared via a maleimide-thiol coupling reaction with uniformly spherical shape under TEM and particle size of 111.30 ± 15.64 nm. tLyp-1-NP exhibited enhanced cellular uptake in both human umbilical vein endothelial cells and Rat C6 glioma cells, increased cytotoxicity of the loaded PTX, and improved penetration and growth inhibition in avascular C6 glioma spheroids. "
|4.||Neurotransmitter Agents (Neurotransmitter)
|6.||Sulfhydryl Compounds (Thiols)
|9.||Membrane Proteins (Integral Membrane Proteins)
|10.||Adenosine Triphosphatases (ATPase)
|1.||Heterologous Transplantation (Xenotransplantation)